AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the company’s management will participate in the following investor conferences in March:
– Leerink Partners 2025 Global Healthcare Conference: Management will participate in investor meetings on March 10, 2025
– Barclays 27th Annual Global Healthcare Conference: Management will participate in investor meetings on March 11, 2025
Please contact your Leerink or Barclays representative or AC Immune to request a one-on-one meeting with AC Immune’s management team at the conferences.